Resuscitated sudden cardiac death in Andersen-Tawil syndrome

Heart Rhythm

Volumn 6, Issue 12, 2009, Pages 1814-1817

  Airey, Kelly J ^a   Etheridge, Susan P ^b   Tawil, Rabi ^c   Tristani Firouzi, Martin ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bidirectional ventricular tachycardia; Ion channelopathy

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; METOPROLOL; POTASSIUM CHLORIDE; PROPOFOL;

ADOLESCENT; ANAMNESIS; ANDERSEN SYNDROME; ARTICLE; CASE REPORT; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; GENE MUTATION; HOLTER MONITORING; HUMAN; PRIORITY JOURNAL; RESUSCITATION; SUDDEN DEATH;

ANDERSEN SYNDROME; CARDIOPULMONARY RESUSCITATION; CHILD; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; TACHYCARDIA, VENTRICULAR; VENTRICULAR PREMATURE COMPLEXES;

EID: 70549110987     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.08.032     Document Type: Article

References (14)

1. Andersen E.D., Krasilnikoff P.A., and Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?. Acta Paediatr Scand 60 (1971) 559-564
2. Sansone V., Griggs R.C., Meola G., et al. Andersen's syndrome: a distinct periodic paralysis. Ann Neurol 42 (1997) 305-312
3. Tawil R., Ptacek L.J., Pavlakis S.G., et al. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 35 (1994) 326-330
4. Plaster N.M., Tawil R., Tristani-Firouzi M., et al. Mutations in kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001) 511-519
5. Chun T.U., Epstein M.R., Dick II M., et al. Polymorphic ventricular tachycardia and kcnj2 mutations. Heart Rhythm 1 (2004) 235-241
6. Zhang L., Benson D.W., Tristani-Firouzi M., et al. Electrocardiographic features in Andersen-Tawil syndrome patients with kcnj2 mutations: characteristic T-U-wave patterns predict the kcnj2 genotype. Circulation 111 (2005) 2720-2726
7. Donaldson M.R., Jensen J.L., Tristani-Firouzi M., et al. Pip(2) binding residues of kir2.1 are common targets of mutations causing Andersen syndrome. Neurology 60 (2003) 1811-1816
8. Peters S., Schulze-Bahr E., Etheridge S.P., et al. Sudden cardiac death in Andersen-Tawil syndrome. Europace 9 (2007) 162-166
9. Seemann G., Sachse F.B., Weiss D.L., et al. Modeling of ik1 mutations in human left ventricular myocytes and tissue. Am J Physiol Heart Circ Physiol 292 1 (2007) H549-H559
10. Trapani G., Altomare C., Liso G., et al. Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Current medicinal chemistry 7 (2000) 249-271
11. Hug Jr. C.C., McLeskey C.H., Nahrwold M.L., et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg 77 (1993) S21-S29
12. Buljubasic N., Marijic J., Berczi V., et al. Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells. Anesthesiology 85 (1996) 1092-1099
13. Smith A.H., Fish F.A., and Kannankeril P.J. Andersen-Tawil syndrome. Indian Pacing Electrophysiol J 6 (2006) 32-43
14. Viskin S. Cardiac pacing in the long qt syndrome: review of available data and practical recommendations. J Cardiovasc Electrophysiol 11 (2000) 593-600